An ergocryptine as a lactation inhibitor.
D000284:Administration, Oral; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D001966:Bromine / Q000494:pharmacology; D002741:Chlorotrianisene / Q000008:administration & dosage / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004876:Ergot Alkaloids / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D008598:Menstruation; D010919:Placebos; D049590:Postpartum Period; D011247:Pregnancy; D011674:Pulse / Q000187:drug effects; D013997:Time Factors
D004876:Ergot Alkaloids; D010919:Placebos; D002741:Chlorotrianisene; D001966:Bromine